The source said the government will purchase more than 28 crore of vaccine in October. It includes 22 crore Covishield vaccines, six crore Covaxin and 60 lakh of DNA vaccine.
The ZyCov-D vaccine was approved by the Indian regulatory authority in August 2020. The three-dose DNA vaccine has 66.6% efficacy against Covid. Instead of a needle, he uses an applicator to inject laboratory-produced DNA into the skin.
The Zydus Cadila vaccine was due to be deployed during the first week of October. Asked about the delay in vaccine rollout, NITI Ayog (Health) member Dr VK Paul said last week that the Zydus Cadila vaccine was not given using conventional syringes or needles, but via an applicator, which will be used for the first time. in the countryside.
Paul said: “We are working on the trainers. The training programs are conducted on the use of applicators. We are also addressing the logistics issues of the vaccine and it will soon be part of the Covid-19 vaccination campaign.”
The ZyCoV-D vaccine will be administered to the 12-18 age group.
Meanwhile, India’s immunization coverage broke the 96 crore mark through Wednesday morning with the administration of 50 63,845 doses of the vaccine in the past 24 hours. India is working towards reaching the 100 crore vaccine mark very soon. The source said it can be done within 2-3 days. He added that all ministers and MPs will spread the success in their constituencies.
However, over 8.43 crore and unused Covid vaccine doses are still available with States / UTs to administer, according to data shared by the Union Department of Health.